HYDROCHLOROTHIAZIDE - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for hydrochlorothiazide and what is the scope of patent protection?
Hydrochlorothiazide
is the generic ingredient in sixty-three branded drugs marketed by Alembic Pharms Ltd, Apotex, Aurobindo Pharma, Chartwell Molecular, Hikma Intl Pharms, Ipca Labs Ltd, Ivax Sub Teva Pharms, Jubilant Cadista, Norvium Bioscience, Prinston Inc, Sciegen Pharms Inc, Sun Pharm Inds Inc, Unichem, Teva Branded Pharm, Morton Grove, Roxane, Novartis, Halsey, Abc Holding, Accord Hlthcare, Actavis Elizabeth, Alra, Ascot, Aurolife Pharma Llc, Barr, Chartwell Rx, Dava Pharms Inc, Elkins Sinn, Heather, Heritage, Impax Labs, Inwood Labs, Lannett Co Inc, Leading, Mast Mm, Mylan, Oxford Pharms, Pvt Form, Solvay, Sun Pharm Industries, Superpharm, Teva, Usl Pharma, Vangard, Warner Chilcott, Watson Labs, Watson Labs Teva, West Ward, Whiteworth Town Plsn, Merck, Abbvie, Sanofi Aventis Us, Alembic, Apotex Inc, Atlas Pharms Llc, Aurobindo Pharma Ltd, Dr Reddys Labs Ltd, Hikma, Hisun Pharm Hangzhou, Lupin Ltd, Macleods Pharms Ltd, Sandoz, Watson Labs Inc, Schering, Glaxosmithkline, Aurobindo, Corepharma, Epic Pharma Llc, Invagen Pharms, Lupin, Sun Pharm Inds Ltd, Almatica, Organon, Granules, Teva Pharms, Torrent Pharms, Zydus Pharms Usa Inc, Parke Davis, Purepac Pharm, Rising, Strides Pharma, Concordia, Validus Pharms, Sun Pharm Inds, Glenmark Pharms, Ucb Inc, Cosette, Alkem Labs Ltd, Natco Pharma Usa, Teva Pharms Usa, Torrent, Umedica, Zydus Pharms, Wyeth Ayerst, Wyeth Pharms Inc, Duramed Pharms Barr, Ani Pharms, Pfizer Pharms, Pharmeral, Pfizer, Mutual Pharm, Ivax Pharms, Lederle, Upsher Smith, Boehringer Ingelheim, Glenmark Pharms Ltd, Natco, Glaxosmithkline Llc, Cadila, Vitarine, Aurobindo Pharma Usa, Am Therap, Pliva, Quantum Pharmics, Rubicon, Amneal Pharms, Mylan Pharms Inc, and Zydus Lifesciences, and is included in three hundred and thirty-three NDAs. Additional information is available in the individual branded drug profile pages.There are thirty-two drug master file entries for hydrochlorothiazide. Forty-five suppliers are listed for this compound. There are seven tentative approvals for this compound.
Summary for HYDROCHLOROTHIAZIDE
US Patents: | 0 |
Tradenames: | 63 |
Applicants: | 118 |
NDAs: | 333 |
Drug Master File Entries: | 32 |
Finished Product Suppliers / Packagers: | 45 |
Raw Ingredient (Bulk) Api Vendors: | 134 |
Clinical Trials: | 383 |
Patent Applications: | 6,812 |
Drug Prices: | Drug price trends for HYDROCHLOROTHIAZIDE |
Drug Sales Revenues: | Drug sales revenues for HYDROCHLOROTHIAZIDE |
What excipients (inactive ingredients) are in HYDROCHLOROTHIAZIDE? | HYDROCHLOROTHIAZIDE excipients list |
DailyMed Link: | HYDROCHLOROTHIAZIDE at DailyMed |
Recent Clinical Trials for HYDROCHLOROTHIAZIDE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Insel Gruppe AG, University Hospital Bern | Phase 2 |
University of Bern | Phase 2 |
University Medical Center Groningen | Phase 3 |
Generic filers with tentative approvals for HYDROCHLOROTHIAZIDE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 12.5MG;150MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 12.5MG;300MG | TABLET;ORAL |
⤷ Sign Up | ⤷ Sign Up | 25MG;300MG | TABLET; ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for HYDROCHLOROTHIAZIDE
Drug Class | Thiazide Diuretic |
Physiological Effect | Increased Diuresis |
Medical Subject Heading (MeSH) Categories for HYDROCHLOROTHIAZIDE
Anatomical Therapeutic Chemical (ATC) Classes for HYDROCHLOROTHIAZIDE
US Patents and Regulatory Information for HYDROCHLOROTHIAZIDE
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.